This work was supported by a Vanderbilt Clinical Oncology Research Career Development Program (K12 NCI 2K12CA090625-22A1), the NIH/National Institute for Deafness and Communication Disorders (R25 DC020728), Vanderbilt-Ingram Cancer Center Support Grant (P30CA068485) and Swim Across America.

This protocol was performed at Vanderbilt University Medical Center under IRB#221597. Patients provided written consent for ex vivo 3D scanning and digital mapping of their surgical specimen prior to surgery and the addition of their scan to a 3D specimen model biorepository. Inclusion criteria were patients 18 and older with a suspected or biopsy-proven head and neck neoplasm undergoing surgical resection. 3D specimen maps were created based on surgeon and pathologist preference and staff availability.
<p c...

Advanced CAD Imaging for Surgical Margin Analysis in Cancer Care

<ol>
	<li>Looser, K. G., Shah, J. P., Strong, E. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+significance+of+&amp;#34;positive&amp;#34;+margins+in+surgically+resected+epidermoid+carcinomas.">The significance of &amp;#34;positive&amp;#34; margins in surgically resected epidermoid carcinomas.</a> Head Neck Surg. 1 (2), 107-111 (1978).</li><li>Binahmed, A., Nason, R. W., Abdoh, A. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+clinical+significance+of+the+positive+surgical+margin+in+oral+cancer.">The clinical significance of the positive surgical margin in oral cancer.</a> Oral Oncol. 43 (8), 780-784 (2007).</li><li>Orosco, R. K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Positive+surgical+margins+in+the+10+most+common+solid+cancers.">Positive surgical margins in the 10 most common solid cancers.</a> Sci Rep. 8 (1), 5686 (2018).</li><li>Prasad, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Trends+in+positive+surgical+margins+in+cT3-T4+oral+cavity+squamous+cell+carcinoma.">Trends in positive surgical margins in cT3-T4 oral cavity squamous cell carcinoma.</a> Otolaryngol Head Neck Surg. 169 (5), 1200-1207 (2023).</li><li>Byers, R. M., Bland, K. I., Borlase, B., Luna, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+prognostic+and+therapeutic+value+of+frozen+section+determinations+in+the+surgical+treatment+of+squamous+carcinoma+of+the+head+and+neck.">The prognostic and therapeutic value of frozen section determinations in the surgical treatment of squamous carcinoma of the head and neck.</a> Am J Surg. 136 (4), 525-528 (1978).</li><li>DiNardo, L. J., Lin, J., Karageorge, L. S., Powers, C. N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Accuracy,+utility,+and+cost+of+frozen+section+margins+in+head+and+neck+cancer+surgery.">Accuracy, utility, and cost of frozen section margins in head and neck cancer surgery.</a> Laryngoscope. 110 (10 Pt 1), 1773-1776 (2000).</li><li>Gandour-Edwards, R. F., Donald, P. J., Lie, J. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Clinical+utility+of+intraoperative+frozen+section+diagnosis+in+head+and+neck+surgery:+a+quality+assurance+perspective.">Clinical utility of intraoperative frozen section diagnosis in head and neck surgery: a quality assurance perspective.</a> Head Neck. 15 (5), 373-376 (1993).</li><li>Ikemura, K., Ohya, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+accuracy+and+usefulness+of+frozen-section+diagnosis.">The accuracy and usefulness of frozen-section diagnosis.</a> Head Neck. 12 (4), 298-302 (1990).</li><li>Remsen, K. A., Lucente, F. E., Biller, H. F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Reliability+of+frozen+section+diagnosis+in+head+and+neck+neoplasms.">Reliability of frozen section diagnosis in head and neck neoplasms.</a> Laryngoscope. 94 (4), 519-524 (1984).</li><li>Weinstock, Y. E., Alava, I., Dierks, E. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Pitfalls+in+determining+head+and+neck+surgical+margins.">Pitfalls in determining head and neck surgical margins.</a> Oral Maxillofac Surg Clin North Am. 26 (2), 151-162 (2014).</li><li>Catanzaro, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Intraoperative+navigation+in+complex+head+and+neck+resections:+indications+and+limits.">Intraoperative navigation in complex head and neck resections: indications and limits.</a> Int J Comput Assist Radiol Surg. 12 (5), 881-887 (2017).</li><li>Black, C., Marotti, J., Zarovnaya, E., Paydarfar, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Critical+evaluation+of+frozen+section+margins+in+head+and+neck+cancer+resections.">Critical evaluation of frozen section margins in head and neck cancer resections.</a> Cancer. 107 (12), 2792-2800 (2006).</li><li>Miller, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Virtual+3D+specimen+mapping+in+head+&amp;+neck+oncologic+surgery.">Virtual 3D specimen mapping in head &amp; neck oncologic surgery.</a> Laryngoscope. , (2023).</li><li>Sharif, K. F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+computer-aided+design+margin:+Ex+vivo+3D+specimen+mapping+to+improve+communication+between+surgeons+and+pathologists.">The computer-aided design margin: Ex vivo 3D specimen mapping to improve communication between surgeons and pathologists.</a> Head Neck. 45 (1), 22-31 (2023).</li><li>Sharif, K. F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Enhanced+intraoperative+communication+of+tumor+margins+using+3D+scanning+and+mapping:+the+computer-aided+design+margin.">Enhanced intraoperative communication of tumor margins using 3D scanning and mapping: the computer-aided design margin.</a> The Laryngoscope. 133 (8), 1914-1918 (2023).</li></ol>

Traditionally, there is no visual representation of a resected cancer specimen. Pathologic processing often destroys the specimen. Prior work has demonstrated the feasibility and utility of 3D scanning of oncologic specimens followed by virtual annotation of the models to create 3D specimen maps which are representative of pathologic processing13,14,15. This provides the multidisciplinary care team with a visual model of the ana...

The goal of oncologic resection is the complete removal of cancer with surgical margins microscopically clear of tumor cells. In head and neck cancer, the surgical margin status is the most important pathologic risk factor1. A positive surgical margin increases the risk of 5-year local recurrence and all-cause mortality by &#62;90%2. Despite advances in medical technology and surgical techniques in recent years, positive margin rates in head and neck cancer remain high3. For locally advanced oral cavity cancers, the positive margin rate within the United States is 18.1%4.
For head and neck surgeons to ensure complete oncologic resection while minimizing disruption of surrounding structures, intraoperative sampling of margins via frozen section analysis (FSA) is performed. FSA provides a rapid intraoperative pathology consultation that is widely used and is the standard of care5,6,7,8,9. Fresh tissue is frozen, thinly sliced, placed on a glass slide, and stained for immediate interpretation while the patient is still under anesthesia.
Head and neck oncologic specimens present several distinct challenges in accurately assessing margin status, including the anatomic complexity of head and neck cancer specimens, the minimal reserve in the head and neck region for wide excision given the proximity to vital structures such as the eyes, face, and important nerves and vasculature, and the multiple tissue types often present in the resected specimen (i.e., mucosa, cartilage, muscle, bone)10,11. Thus, a specimen-based approach to margin analysis requires an enhanced level of communication between surgeon and pathologist12. A face-to-face conversation is often warranted to ensure correct specimen orientation and discussion of concerning margins. However, this is not always safe or feasible as it requires either the surgeon to leave the operating room (OR) while the patient remains under general anesthesia or the pathologist to leave the gross pathology lab, interrupting their workflow. In addition, there may be a significant travel time between the OR and the pathology lab, or in some cases, the pathology lab may be off-site altogether.
Following FSA, the oncologic specimen is fixed in formalin and formally processed through inking, sectioning, and margin sampling. Slides are created and microscopically interpreted by the pathologist to create a final pathology report. For complex head and neck cancer resection, this can often take 1-2 weeks. Unfortunately, processing of the specimen commonly results in the destruction of the resected cancer specimen. This may create further confusion as the final pathology report, multidisciplinary tumor board discussions, adjuvant radiation therapy planning, and re-resection in the setting of positive margins, must all proceed without a visual record of the oncologic specimen and its pathologic processing.
To address this clinical unmet need, we have developed a 3D scanning and specimen mapping protocol to enhance communication between surgeons, pathologists, and other members of the multidisciplinary cancer care team.

<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>Computer Aided Design Software</td>
			<td>MeshMixer</td>
			<td></td>
			<td>Virtual annotation software for 3D models</td>
		</tr>
		<tr>
			<td>Digital Camera or Cameraphone</td>
			<td>iPhone</td>
			<td></td>
			<td>May use iPhone camera or any digital camera available&#160;</td>
		</tr>
		<tr>
			<td>EinScan SP V2 Platinum Desktop 3D Scanner</td>
			<td>Shining 3D</td>
			<td></td>
			<td>3D scanner hardware</td>
		</tr>
		<tr>
			<td>ExScan Software; Solid Edge SHINING 3D Edition</td>
			<td>Shining 3D</td>
			<td></td>
			<td>3D capture software included with purchase of 3D Scanner</td>
		</tr>
		<tr>
			<td>External Mouse</td>
			<td>Microsoft&#160;</td>
			<td></td>
			<td></td>
		</tr>
		<tr>
			<td>Laptop Computer</td>
			<td>Dell XP5</td>
			<td>00355-60734-40310-AAOEM</td>
			<td>Laptop Requirements: 
			USB: 1 &#215;USB 2.0 or 3.0; OS: Win 7, 8 or 10 (64 bit); 
			Graphic Card: Nvidia series; Graphic memory: &#62;1 G; 
			CPU: Dual-core i5 or higher; Memory: &#62;8 G</td>
		</tr>
		<tr>
			<td>Microsoft Office Suite</td>
			<td>Microsoft</td>
			<td></td>
			<td></td>
		</tr>
		<tr>
			<td>Mobile Presentation Cart</td>
			<td>Oklahoma Sound</td>
			<td>PRC450</td>
			<td></td>
		</tr>
		<tr>
			<td>PowerPoint Software</td>
			<td>Microsoft Office</td>
			<td></td>
			<td>Presentation software</td>
		</tr>
		<tr>
			<td>Sit-Stand Mobile Desk Cart</td>
			<td>Seville Classics</td>
			<td></td>
			<td></td>
		</tr>
		<tr>
			<td>USB-c Device Converter</td>
			<td>TRIPP-LITE</td>
			<td>U442-DOCK3-B</td>
			<td>Necessary only if laptop does not have USB</td>
		</tr>
	</tbody>
</table>

enhanced communication of tumor margins using 3d scanning and mapping

After oncologic resection of malignant tumors, specimens are sent to pathology for processing to determine the surgical margin status. These results are communicated in the form of a written pathology report. The current standard-of-care pathology report provides a written description of the specimen and the sites of margin sampling without any visual representation of the resected tissue. The specimen itself is typically destroyed during sectioning and analysis. This often leads to challenging communication between pathologists and surgeons when the final pathology report is confirmed. Furthermore, surgeons and pathologists are the only members of the multidisciplinary cancer care team to visualize the resected cancer specimen. We have developed a 3D scanning and specimen mapping protocol to address this unmet need. Computer-aided design (CAD) software is used to annotate the virtual specimen clearly showing sites of inking and margin sampling. This map can be utilized by various members of the multidisciplinary cancer care team.

Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication

Enhanced Communication of Tumor Margins Using 3D Scanning and Mapping

The scope of our research is to use 3D scanning and augmented reality technology to improve communication of cancer surgery results among the multidisciplinary cancer care team. More specifically, we're hoping to allow for a surgeon to re-resect cancer more precisely and allow for more precise radiation therapy. In the hospital environment, space is often limited, and finding additional room for extra personnel and equipment can be difficult.The learning curve on this protocol can also be challenging, especially for those without prior experience in 3D scanning and computer-aided design. We've created a 3D scanning and virtual mapping protocol for cancer specimens, providing a permanent visual record to go alongside written pathology reports. This is a powerful communication tool for the entire cancer care team and is now being investigated in multidisciplinary tumor board discussions, as well as adjuvant radiation therapy treatment planning.When a surgical specimen is processed for pathologic analysis, it is often destroyed, without any visual documentation. This results in lengthy written pathology reports and can often lead to challenging clinical scenarios in cases of a close or positive margin. Our research protocol creates an interactive, permanent visual record of the resected cancer specimen.Our protocol offers a novel visual representation of a surgically resected oncologic specimen and a map of how it was processed pathologically. This data previously did not exist and now allows providers to look back at a specimen for reference, multidisciplinary care discussions, and future treatment planning.

From October 2021 to April 2023, 28 head and neck oncologic specimens were 3D scanned and virtually mapped according to this protocol. These results were previously published13. The majority of the surgical specimens were squamous cell carcinoma (SCC) (86%, n = 24), with the most common anatomic subsites being oral cavity (54%, n = 15) and larynx (29%, n = 8).
In all cases, specimen maps were shared with attending surgeons and pathologists prior to the evaluation of the...

Watch this Scientific Journal Video about Enhanced Communication of Tumor Margins Using 3D Scanning and Mapping at JoVE.com

A novel method for 3D scanning and virtual mapping of cancer resections is proposed with the goal of improving communication among the multidisciplinary cancer care team.

After oncologic resection of malignant tumors, specimens are sent to pathology for processing to determine the surgical margin status. These results are ...

enhanced-communication-of-tumor-margins-using-3d-scanning-and-mapping

Research

JoVE Journal

Medicine

321 vues.  Vanderbilt University Medical Center. La portée de notre recherche est d’utiliser la numérisation 3D et la technologie de réalité augmentée pour améliorer la communication des résultats de la chirurgie du cancer au sein de l’équipe multidisciplinaire de soins contre le cancer. Plus précisément, nous espérons permettre à un chirurgien de réséquer le cancer avec plus de précision et de permettre une radiothérapie plus précise. Dans l’environnement hospitalier, l’espace est souvent limité et il peut être d...